Physician profile
Sandeep Lahoti
NPI 1134106602
$2,263.47
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,267 · 2020: $282 · 2021: $672 · 2022: $24.97 · 2023: $17.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $17.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $17.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $821.21 | 2019-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $369.93 | 2019-2021 | |
| Janssen Biotech, INC. | $315.15 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $200.14 | 2019-2021 | |
| Pfizer INC. | $144.66 | 2019 | |
| Boston Scientific Corporation | $99.63 | 2019 | |
| Shire North American Group INC | $70.76 | 2019 | |
| Covidien LP | $40.28 | 2019 | |
| Merck Sharp & Dohme LLC | $39.47 | 2019 | |
| Braintree Laboratories, INC. | $30.85 | 2019-2020 | |
| Ucb, INC. | $21.77 | 2020 | |
| Apollo Endosurgery US INC | $20.75 | 2019 | |
| Dynavax Technologies Corporation | $19.32 | 2019 | |
| Daiichi Sankyo INC. | $19.11 | 2019 | |
| Ferring Pharmaceuticals INC. | $16.46 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $13.31 | 2021 | |
| Shionogi INC | $11.53 | 2019 | |
| Romark Laboratories, Lc | $9.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandeep Lahoti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.